FDA Approves Orlynvah for Uncomplicated UTIs in Adult Women

93 Views

Emedinexus 11 February 2025

The FDA has approved Orlynvah tablets for treating uncomplicated urinary tract infections (uUTIs) in adult women with limited or no alternative oral antibiotic options. This treatment targets infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis, providing a crucial option amid rising antibiotic resistance.

To comment on this article,
create a free account.

Already registered?

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.